Press release

CPT and Evonik jointly present LCD display with solution-type metal oxide semiconductor iXsenic® inside on this year’s Display Week

May 31, 2016

During Display Week trade fair in San Francisco German specialty chemical company Evonik Industries and Taiwanese display maker Chunghwa Picture Tubes (CPT) have given a joint presentation to show an enhanced LCD display with iXsenic® metal oxide semiconductor inside.

iXsenic® is a solution-processable inorganic metal oxide semiconductor for the display industry supplied by the Resource Efficiency segment of Evonik. It is applied under ambient conditions: no vacuum environment is needed which results in process simplifications, high yield and cost advantages. iXsenic® is best applied via slot-die coating.

The Taiwanese display maker Chunghwa Picture Tubes (CPT) is dedicated to offer full-sized product line and position itself as a leader for visual telecommunication products and the all-around innovator for optronic technology.

After CPT’s demo display presentation last year on Touch Taiwan CPT and Evonik have again joined forces to apply the iXsenic® metal oxide semiconductor on CPT’s Gen4 mass production line. The result – a 5.8 inch mobile phone display with higher performance and reliability – was now shown on SID’s Display Week.

“It’s a great honor to present our progress on the Display Week which is one of the most important trade fairs for the display industry in the world,” says Prof. Ralf Anselmann, Vice President Electronic Solutions at Evonik. “And we are proud to do it together with our partner, display maker Chunghwa Picture Tubes.”

“With this display we have again shown the mass production suitability of iXsenic® in the coating process,” comments Dr. Jang-Jeng Liang, CTO at CPT. “And we are improving - we are now constantly moving closer towards mass production.”

Besides the demo display presentation Evonik had another appearance at the Display Week fair: Together with SCREEN FT Evonik presented first results of their strategic partnership and gave an outlook for the future: It was stated that both companies will offer a mass manufacturing solution for metal oxide semiconductor technology iXsenic® until 2017.

For further information please visit our websites www.iXsenic.com (English) and www.iXsenic.com.cn (Mandarin).

Joint author interview of CPT and Evonik at SID 2016

Joint author interview of CPT and Evonik at SID 2016

Contact

Ariel Fang

Contact

  • Company information

    Evonik, the creative industrial group from Germany, is one of the world leaders
    in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2015more than 33,500 employees generated sales of around €13.5billion and an operating profit (adjusted EBITDA) of about €2.47 billion.

  • Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now has around 3,000 employees in the Greater China region, the regional sales reached over €1.3 billion in 2015.

  • Disclaimer

    In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.